Exhibit 99.1(b)6
CONSOLIDATED STATEMENTS OF CASH FLOWS
NDCHealth Corporation and Subsidiaries
(In thousands)
Year Ended May 31, | ||||||||
2002 | 2001 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 43,410 | $ | 32,540 | ||||
Adjustments to reconcile net income to cash provided by operating activities: | ||||||||
Equity in losses of affiliated companies | 2,064 | 751 | ||||||
Non-cash restructuring and impairment charges | — | 930 | ||||||
Income from discontinued operations | — | (8,323 | ) | |||||
Depreciation and amortization | 24,374 | 34,745 | ||||||
Deferred income taxes | 4,080 | 10,977 | ||||||
Provision for bad debts | 1,619 | 1,322 | ||||||
Valuation adjustment in Medscape investment | — | 6,953 | ||||||
Other, net | 269 | 54 | ||||||
Changes in assets and liabilities which provided (used) cash, net of the effects of acquisitions: | ||||||||
Accounts receivable, net | (6,429 | ) | (4,121 | ) | ||||
Prepaid expenses and other assets | (3,492 | ) | (15,539 | ) | ||||
Accounts payable and accrued liabilities | (1,812 | ) | 10,018 | |||||
Deferred income | 636 | (9,114 | ) | |||||
Income taxes | (2,067 | ) | 1,857 | |||||
Net cash provided by operating activities | 62,652 | 63,050 | ||||||
Cash flows from investing activities: | ||||||||
Capital expenditures | (30,985 | ) | (32,915 | ) | ||||
Business acquisitions, net of acquired cash | (119,626 | ) | (23,224 | ) | ||||
Business divestiture | — | 20,000 | ||||||
Investments and other non-current assets | (14,310 | ) | (13,789 | ) | ||||
Net cash used in investing activities | (164,921 | ) | (49,928 | ) | ||||
Cash flows from financing activities: | ||||||||
Net short-term borrowings (repayments) | 91,000 | (68,500 | ) | |||||
Credit facility fees | (889 | ) | — | |||||
Net principal payments under capital lease arrangements and other long-term debt | (2,371 | ) | (4,814 | ) | ||||
Net issuances related to stock activities | 6,559 | 7,360 | ||||||
Dividends paid | (5,457 | ) | (8,762 | ) | ||||
Net cash provided by (used in) financing activities | 88,842 | (74,716 | ) | |||||
Cash flows from discontinued operations: | ||||||||
Cash provided by tax benefits of discontinued operations | 21,233 | — | ||||||
Cash used in discontinued operations | (6,779 | ) | (5,375 | ) | ||||
Cash dividend from Global Payments Inc. | — | 77,600 | ||||||
Net cash provided by discontinued operations | 14,454 | 72,225 | ||||||
Increase in cash and cash equivalents | 1,027 | 10,631 | ||||||
Cash and cash equivalents, beginning of period | 12,420 | 1,789 | ||||||
Cash and cash equivalents, end of period | $ | 13,447 | $ | 12,420 | ||||